Art

J-GLOBAL ID：201202236603732910   Reference number：12A1699208

Pertuzumab Monotherapy After Trastuzumab-Based Treatment and Subsequent Reintroduction of Trastuzumab: Activity and Tolerability in Patients With Advanced Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer

トラスツズマブベース治療後のペルツズマブ単独療法とその後のトラスツズマブ再導入: 進行性ヒト上皮成長因子受容体2陽性乳癌患者における活性と忍容性

Author (18)： CORTES Javier (Vall d’Hebron Univ. Hospital) ,  FUMOLEAU Pierre (Centre Georges-Francois Leclerc, Dijon) ,  BIANCHI Giulia Valeria (Fondazione Istituto di Ricovero e Cura a Carattere Scientifico Istituto Nazionale Tumori) ,  PETRELLA Teresa M. (Ottawa Regional Cancer Centre, Ottawa, Ontario) ,  GELMON Karen (British Columbia Cancer Agency, British Columbia, CAN) ,  PIVOT Xavier (Centre Hospitalier Universitaire Jean Minjoz, Besancon) ,  VERMA Shailendra (Sunnybrook Health Sci. Centre, Toronto) ,  ALBANELL Joan (Hospital del Mar, Barcelona) ,  CONTE Pierfranco (Univ. Hospital, Modena) ,  LLUCH Ana (Hospital Clinico Universitario, Valencia, ESP) ,  SALVAGNI Stefania (Ospedale Regionale, Parma, ITA) ,  SERVENT Veronique (Centre Oscar Lambret, Lille, FRA) ,  GIANNI Luca (Istituto Nazionale, Milan) ,  SCALTRITI Maurizio (Massachusetts General Hospital Cancer Center, MA) ,  ROSS Graham A. (Roche Products, Welwyn Garden City, GBR) ,  DIXON Joanna (Roche Products, Welwyn Garden City, GBR) ,  SZADO Tania (Roche Products, Welwyn Garden City, GBR) ,  BASELGA Jose (Massachusetts General Hospital Cancer Center, MA)
Material： Journal of Clinical Oncology  (J Clin Oncol)
Volume： 30  Issue： 14  Page： 1594-1600  Publication year： May. 10, 2012 
JST Material Number： E0307D  ISSN： 0732-183X  Document type： Article
Country of issue： United States (USA)  Language： ENGLISH (EN)

Terms in the title (10)： トラスツズマブ ,  治療 ,  ペルツズマブ ,  単独療法 ,  ヒト ,  上皮成長因子受容体 ,  乳癌 ,  患者 ,  活性 ,  忍容性